No abstract available
Keywords:
COVID-19; Clinical Outcome; Hyperlipasemia; Lipase; Pancreatitis; SARS-CoV-2; Severity.
MeSH terms
-
Biomarkers / blood
-
COVID-19 / diagnosis
-
COVID-19 / epidemiology*
-
Clinical Enzyme Tests
-
Humans
-
Lipase / blood*
-
Pancreatic Diseases / blood
-
Pancreatic Diseases / diagnosis
-
Pancreatic Diseases / epidemiology*
-
Predictive Value of Tests
-
Prevalence
-
Prognosis
-
Risk Assessment
-
Risk Factors
-
Severity of Illness Index
-
Up-Regulation
Substances
-
Biomarkers
-
Lipase
-
PNLIP protein, human